Targeted genome editing in acute lymphoblastic leukemia: a review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted genome editing in acute lymphoblastic leukemia: a review

Published:2018-07-17 Issue:1 Volume:18 Page:
ISSN:1472-6750
Container-title:BMC Biotechnology
language:en
Short-container-title:BMC Biotechnol

Author:

Montaño Adrián,Forero-Castro Maribel,Hernández-Rivas Jesús-María,García-Tuñón Ignacio,Benito Rocío

Funder

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

Publisher

Springer Science and Business Media LLC

Subject

Biotechnology

Link

http://link.springer.com/content/pdf/10.1186/s12896-018-0455-9.pdf

Reference91 articles.

1. Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol. 2017;35(9):975–83.

2. Nemudryi AA, Valetdinova KR, Medvedev SP, Zakian SM. TALEN and CRISPR/Cas genome editing systems: tools of discovery. Acta Nat. 2014;6(3):19–40.

3. Chan LN, Chen Z, Braas D, Lee JW, Xiao G, Geng H, Cosgun KN, Hurtz C, Shojaee S, Cazzaniga V, et al. Metabolic gatekeeper function of B-lymphoid transcription factors. Nature. 2017;542(7642):479–83.

4. Navarro JM, Touzart A, Pradel LC, Loosveld M, Koubi M, Fenouil R, Le Noir S, Maqbool MA, Morgado E, Gregoire C, et al. Site- and allele-specific polycomb dysregulation in T-cell leukaemia. Nat Commun. 2015;6:6094.

5. Rahman S, Magnussen M, Leon TE, Farah N, Li Z, Abraham BJ, Alapi KZ, Mitchell RJ, Naughton T, Fielding AK, et al. Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia. Blood. 2017;129(24):3221–6.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatic Genome Editing: Technical Challenges and Ethical Appraisal;European Journal of Medical and Health Research;2024-05-01

2. A CRISPR interference strategy for gene expression silencing in multiple myeloma cell lines;Journal of Biological Engineering;2023-05-04

3. CRISPR-Cas9-based Strategies for Acute Lymphoblastic Leukemia Therapy;Leukemia - From Biology to Clinic;2023-03-01

4. El debate ético y de regulación sobre el uso de CRISPR-Cas9 en la línea germinal humana;Universitas Médica;2021-10-07

5. Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations;Pharmaceutics;2021-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3